Oxbridge Biotech Roundtable (OBR) and SR One, the venture capital arm of GlaxoSmithKline, have teamed up again for the OneStart competition - the largest biotech startup accelerator program in the world - to offer young innovators from all disciplines the chance to win $150k in no-strings attached grant money (non-dilutive, no IP rights reserved) and free lab space to transform their ideas into a successful business.
Applications are now open until December 1st 2014. To learn more about the program and start building your team, visit http://onestart.co/.
Applications are now open until December 1st 2014. To learn more about the program and start building your team, visit http://onestart.co/.
Comments
Post a Comment